Scientists at Apichope Bio Pharmaceutical Co. Ltd., Guangzhou Lianrui Pharmaceutical Co. Ltd. and Guangzhou Runlin Pharmaceutical Technology Co. Ltd. have identified proteolysis targeting chimeras ...

Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label StudyDemonstrated Clinical ...

Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with ...

Co. Ltd. has synthesized proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety covalently linked to a target protein binding moiety through a linker ...

VIR-5818 is under clinical development by Vir Biotechnology and currently in Phase II for Metastatic Breast Cancer.

Opaganib is under clinical development by RedHill Biopharma and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global leader in AI-driven protein design, announced the successful completion of Series A funding rounds, raising tens of millions of USD, led ...

Scientists have has pioneered antivirals targeting viral methyltransferases, offering a new strategy for treating RNA and DNA ...

Groundbreaking 'Whole Body' Study will be conducted by Dr. Amy Paller at Northwestern University Up to eight subjects will have QRX003 applied twice daily to greater than 80% of their body surface are ...

Interaction result: Receiving Trodelvy while taking certain protease inhibitors can increase the risk of side effects from Trodelvy. Interaction explained: Trodelvy is broken down in your body by ...

"Malcolm in the Middle" is making a return! The beloved family sitcom will air a limited, four-episode run on Disney+ with stars Frankie Muniz, Bryan Cranston and Jane Kaczmarek all back in their ...

A Private Limited Company (PLC) is a famous business structure offering its shareholders several advantages. Some of the advantages of Private Limited Company include the following: Overall, a Private ...